SARAH LEVAN: Open Payments
NPI 1720152911 · CLINTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 77 payments from 20 companies in 2025. Trend: 2023 $1,398 · 2024 $1,525 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $264 |
| PFIZER INC. | 14 | $217 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| GlaxoSmithKline, LLC. | 7 | $137 |
| ABBVIE INC. | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $79 |
| Dexcom, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
Products named: TRELEGY ELLIPTA, Ozempic, XIFAXAN, FARXIGA, Rybelsus, VOQUEZNA, NURTEC ODT, ELIQUIS.
Industry payments across TN — which companies pay providers there.
